Histone deacetylase inhibitors
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
Histone deacetylase (HDAC) inhibitors are a group of agents that inhibit the histone deactylase enzymes. During gene expression DNA coils and uncoils around histones. Histone acetylases, acetylate the lysine residues in core histones and histone deactylases remove the acetyl groups from the lysine residues. These actions are important in the regulation of gene expression.
Histone deacetylase inhibitors prevent the deactylation, affect gene expression and causes apoptosis of tumor cells. Histone deacetylase inhibitors are used to treat cutaneous T-cell lymphoma.
|Drug Name ( View by: Brand | Generic )||Reviews||Ratings|
|romidepsin systemic (Pro, More...)
|belinostat systemic (Pro, More...)
|panobinostat systemic (Pro, More...)
|vorinostat systemic (Pro, More...)
Medical conditions associated with histone deacetylase inhibitors: